相关实验视频
Updated: May 15, 2025

04:48
Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
10.9K
概括
这一案例研究表明,一个Graves'病患者仅使用生活方式干预措施,避免药物副作用,实现了甲状腺功能过高的缓解. 关键干预措施包括饮食改变,补充剂,运动,压力管理和冷水疗法.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 生活方式 医学 医疗
背景情况:
- 格雷夫斯病是一种导致甲状腺功能障碍的自身免疫性疾病,通常用药物,放射性或手术治疗.
- 甲状腺酶受体抗体 (TRAb) 在格雷夫斯病中驱动甲状腺过度活跃.
- 对格雷夫斯病的传统治疗可能会产生显著的副作用,这引起了对替代管理策略的兴趣.
研究的目的:
- 报告一个格雷夫斯病的病例,仅仅通过生活方式干预成功管理.
- 评估饮食变化,特定营养素,运动,压力管理和水疗在治疗甲状腺功能障碍和自身免疫标志物的有效性.
主要方法:
- 一名39岁的女性被诊断患有格雷夫斯病,她选择了改变生活方式,而不是使用甲基马.
- 干预措施包括无乳制品和无质饮食,巴西坚果,定期炼,正念和冷水浸泡.
- 甲状腺功能和自身免疫力的临床和生化标志物被监测了三个月.
主要成果:
- 患者在三个月内实现了甲状腺功能过高的生化缓解 (TSH正常化,自由T4,T3) 和减少自身免疫标记物 (TRAb,TSI).
- 甲状腺刺激激素 (TSH),自由甲状腺素 (自由T4) 和总三甲状腺素 (T3) 水平恢复到正常范围.
- 甲状腺受体抗体 (TRAb) 和甲状腺刺激性免疫球蛋白 (TSI) 水平显著下降,表明自身免疫活性降低.
结论:
- 生活方式干预可能提供一种可行的替代或补充方法来管理Graves病,可能减少对传统疗法的依赖.
- 饮食修改,向补充剂 (巴西坚果),体育活动,减轻压力和暴露在寒冷中,在调节自身免疫性甲状腺疾病方面表现有前途.
- 需要进一步的研究来验证这些生活方式干预措施在更大的队列中用于格雷夫斯病管理.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.0K
Irritable Bowel Syndrome III: Medical and Nursing Management
123
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
123
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
108
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
108
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
253
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
253
Inflammatory Bowel Disease IV: Pharmacological Management
82
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
82
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
91
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
91

